| |
| |
| Exchange: |
New York Stock Exchange |
| Security
Type: |
Common |
| Shares
Out: |
1,340,000,000 |
| Market
Cap: |
127.90(B) |
| Last
Volume: |
23,255,346 |
Avg
Vol: |
0 |
| 52
Week Range: |
$79.61 - $98.43 |
|
| Level
I Sector: |
Health Care |
| Level
II Sector: |
Health Services |
| Level
III Sector: |
Medical Appliances & Equipment |
|
Member Indexes:
|
Rankings:
|
|
| Insider 3 Months : 9.9 |
| Insider 6 Months : 9.9 |
| Insider 3/6 Months : 20.2 |
|
| Guru Rank Number : 164 |
| Guru Rank Value : 8.6 |
| Guru Occurances : 4 |
|
|
|
|
|
| |
|
Company Profile Medtronic is a medical technology, services and solutions company. Co.'s four operating and reportable segments are as follows: Cardiovascular Portfolio, which is made up of the cardiac rhythm and heart failure, structural heart and aortic, and coronary and peripheral vascular divisions; Medical Surgical Portfolio, which is made up of the surgical innovations and respiratory, gastrointestinal, and renal divisions; Neuroscience Portfolio is made up of the cranial and spinal technologies, specialty therapies, and neuromodulation divisions; and Diabetes Operating Unit, which develops, manufactures, and markets products and services for the management of Type 1 and Type 2 diabetes.
|
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
|
3m +/-:
|
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
|
Actions:
|
|
|
| B |
Buy |
| S |
Sell |
| OE |
Option
Exercised |
| A |
Acquired |
| D |
Disposed |
| AB |
Automatic
Buy |
| AS |
Automatic
Sell |
| IO |
Initial
Ownership |
|
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
| |
| |
Summary (Direct Transactions Only)  |
3 Months |
6 Months |
12 Months |
24 Months |
| Total Shares Bought |
5,000 |
5,000 |
5,000 |
5,000 |
| Total Buy Value |
$462,750 |
$462,750 |
$462,750 |
$462,750 |
| Total People Bought |
1 |
1 |
1 |
1 |
| Total Buy Transactions |
2 |
2 |
2 |
2 |
| Total Shares Sold |
8,605 |
8,605 |
30,892 |
86,551 |
| Total Sell Value |
$788,048 |
$788,048 |
$2,699,417 |
$7,395,078 |
| Total People Sold |
1 |
1 |
2 |
5 |
| Total Sell Transactions |
1 |
1 |
3 |
7 |
| End Date |
2025-07-13 |
2025-04-11 |
2024-10-11 |
2023-10-12 |
|
| Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
  Kiil Harry Skip |
EVP & President Cardiovascular |
• – – |
2025-09-03 |
4 |
S |
$91.58 |
$788,048 |
D/D |
(8,605) |
35,615 |
|
-5% |
|
| Jellison William R |
Director |
– • – |
2025-08-25 |
4 |
B |
$92.37 |
$230,925 |
D/D |
2,500 |
5,000 |
2.39 |
5% |
|
| Jellison William R |
Director |
– • – |
2025-08-22 |
4 |
B |
$92.73 |
$231,825 |
D/D |
2,500 |
2,500 |
2.39 |
4% |
|
| Marinaro Michael |
EVP, Pres MedSurg and Americas |
• – – |
2025-08-20 |
4 |
D |
$93.22 |
$98,067 |
D/D |
(1,052) |
51,939 |
|
- |
|
| Walter Matthew R. |
SVP, Chief HR Officer |
• – – |
2025-08-01 |
4 |
D |
$89.34 |
$170,639 |
D/D |
(1,910) |
31,857 |
|
- |
|
| Walter Matthew R. |
SVP, Chief HR Officer |
• – – |
2025-08-01 |
4 |
OE |
$0.00 |
$75,114 |
D/D |
3,142 |
32,736 |
|
- |
|
| Wall Brett A. |
EVP & Pres Neuroscience |
• – – |
2025-08-01 |
4 |
D |
$89.34 |
$1,035,808 |
D/D |
(11,594) |
54,937 |
|
- |
|
| Wall Brett A. |
EVP & Pres Neuroscience |
• – – |
2025-08-01 |
4 |
OE |
$0.00 |
$0 |
D/D |
15,249 |
66,531 |
|
- |
|
| Blomquist Denise L. |
Chief Accounting Officer |
• – – |
2025-08-01 |
4 |
D |
$89.34 |
$46,010 |
D/D |
(515) |
12,428 |
|
- |
|
| Blomquist Denise L. |
Chief Accounting Officer |
• – – |
2025-08-01 |
4 |
OE |
$0.00 |
$16,692 |
D/D |
518 |
12,624 |
|
- |
|
| Marinaro Michael |
EVP, Pres MedSurg and Americas |
• – – |
2025-08-01 |
4 |
D |
$89.34 |
$693,546 |
D/D |
(7,763) |
52,991 |
|
- |
|
| Marinaro Michael |
EVP, Pres MedSurg and Americas |
• – – |
2025-08-01 |
4 |
OE |
$0.00 |
$243,828 |
D/D |
9,661 |
55,855 |
|
- |
|
| Smith Gregory L |
EVP Global Ops & Supply Chain |
• – – |
2025-08-01 |
4 |
D |
$89.34 |
$635,565 |
D/D |
(7,114) |
75,957 |
|
- |
|
| Smith Gregory L |
EVP Global Ops & Supply Chain |
• – – |
2025-08-01 |
4 |
OE |
$0.00 |
$0 |
D/D |
11,328 |
83,071 |
|
- |
|
| Kiil Harry Skip |
EVP & President Cardiovascular |
• – – |
2025-08-01 |
4 |
D |
$89.34 |
$674,964 |
D/D |
(7,555) |
44,220 |
|
- |
|
| Kiil Harry Skip |
EVP & President Cardiovascular |
• – – |
2025-08-01 |
4 |
OE |
$0.00 |
$0 |
D/D |
10,457 |
51,775 |
|
- |
|
| Martha Geoffrey |
Chairman and CEO |
• • – |
2025-08-01 |
4 |
D |
$89.34 |
$6,894,815 |
D/D |
(77,175) |
247,125 |
|
- |
|
| Martha Geoffrey |
Chairman and CEO |
• • – |
2025-08-01 |
4 |
OE |
$0.00 |
$3,166,800 |
D/D |
98,324 |
284,923 |
|
- |
|
| Smith Gregory L |
EVP Global Ops & Supply Chain |
• – – |
2025-07-31 |
4 |
D |
$90.24 |
$147,091 |
D/D |
(1,630) |
71,743 |
|
- |
|
| Martha Geoffrey |
Chairman and CEO |
• • – |
2025-07-28 |
4 |
A |
$0.00 |
$0 |
D/D |
37,513 |
225,976 |
|
- |
|
| Quinn Michelle |
EVP, GC and Secretary |
• – – |
2025-07-28 |
4 |
A |
$0.00 |
$0 |
D/D |
21,747 |
21,747 |
|
- |
|
| Pieton Thierry |
EVP & Chief Financial Officer |
• – – |
2025-07-28 |
4 |
A |
$0.00 |
$0 |
D/D |
8,699 |
39,958 |
|
- |
|
| Blomquist Denise L. |
Chief Accounting Officer |
• – – |
2025-07-28 |
4 |
A |
$0.00 |
$0 |
D/D |
2,202 |
12,425 |
|
- |
|
| Marinaro Michael |
EVP, Pres MedSurg and Americas |
• – – |
2025-07-28 |
4 |
A |
$0.00 |
$0 |
D/D |
9,786 |
51,093 |
|
- |
|
| Wall Brett A. |
EVP & Pres Neuroscience |
• – – |
2025-07-28 |
4 |
A |
$0.00 |
$0 |
D/D |
9,786 |
51,282 |
|
- |
|
717 Records found
|
|
Page 1 of 29 |
|
|
1.05 (1.09%) 
